Table 3.
Association between HOUSES and prevalence of chronic diseases in overall cohort and among Non-Hispanic White
| HOUSES (quartile) | Overall | Non-Hispanic White | ||
|---|---|---|---|---|
|
| ||||
| (N=88,010), n (%) | adj. OR (95% CI) | (N=80,699), n (%) | adj. OR (95% CI) | |
| CHD | ||||
|
| ||||
| Q1 (lowest SES) | 2,535 (11.5) | 1.0 (Reference) [P <.001] a | 2,357 (12.7) | 1.0 (Reference) [P <.001] d |
| Q2 | 2,867 (13.0) | 0.87 (0.81, 0.93) | 2,784 (13.4) | 0.84 (0.78, 0.90) |
| Q3 | 2,429 (11.0) | 0.86 (0.80, 0.92) | 2,331 (11.4) | 0.87 (0.81, 0.94) |
| Q4 (highest SES) | 1,754 (8.0) | 0.74 (0.69, 0.80) | 1,693 (8.1) | 0.81 (0.75, 0.88) |
|
| ||||
| Asthma | ||||
|
| ||||
| Q1 (lowest SES) | 2,112 (9.6) | 1.0 (Reference) [P <.001] b | 1,849 (10.0) | 1.0 (Reference) [P <.001] e |
| Q2 | 1,950 (8.9) | 0.90 (0.84, 0.96) | 1,850 (8.9) | 0.91 (0.85, 0.97) |
| Q3 | 1,840 (8.4) | 0.85 (0.80, 0.91) | 1,739 (8.5) | 0.86 (0.80, 0.92) |
| Q4 (highest SES) | 1,699 (7.7) | 0.78 (0.73, 0.83) | 1,627 (7.8) | 0.78 (0.73, 0.84) |
|
| ||||
| Diabetes | ||||
|
| ||||
| Q1 (lowest SES) | 2,330 (10.6) | 1.0 (Reference) [P <.001] c | 2,004 (10.8) | 1.0 (Reference) [P <.001] f |
| Q2 | 2,303 (10.5) | 0.84 (0.78, 0.89) | 2,176 (10.5) | 0.83 (0.78, 0.89) |
| Q3 | 1,905 (8.7) | 0.75 (0.70, 0.80) | 1,741 (8.5) | 0.74 (0.69, 0.80) |
| Q4 (highest SES) | 1,286 (5.8) | 0.56 (0.52, 0.60) | 1,178 (5.6) | 0.56 (0.52, 0.61) |
|
| ||||
| Hypertension | ||||
|
| ||||
| Q1 (lowest SES) | 5,672 (25.8) | 1.0 (Reference) [P <.001] b | 5,180 (28.0) | 1.0 (Reference) [P <.001] e |
| Q2 | 6,789 (30.9) | 0.96 (0.91, 1.01) | 6,558 (31.6) | 0.96 (0.90, 1.01) |
| Q3 | 5,651 (25.7) | 0.80 (0.76, 0.85) | 5,352 (26.1) | 0.78 (0.74, 0.83) |
| Q4 (highest SES) | 4,401 (20.0) | 0.64 (0.61, 0.68) | 4,209 (20.1) | 0.64 (0.60, 0.67) |
|
| ||||
| Mood disorder | ||||
|
| ||||
| Q1 (lowest SES) | 6,534 (29.7) | 1.0 (Reference) [P <.001] b | 5,872 (31.7) | 1.0 (Reference) [P <.001] e |
| Q2 | 5,737 (26.1) | 0.78 (0.75, 0.81) | 5,520 (26.6) | 0.79 (0.76, 0.83) |
| Q3 | 5,309 (24.1) | 0.72 (0.69, 0.75) | 5,057 (24.6) | 0.72 (0.69, 0.75) |
| Q4 (highest SES) | 4,683 (21.3) | 0.61 (0.58, 0.63) | 4,531 (21.7) | 0.61 (0.59, 0.64) |
a
adjusted for age, gender, ethnicity, hypertension, diabetes, hyperlipidemia, and obesity;
b
adjusted for age, gender and ethnicity;
c
adjusted for age, gender, ethnicity, hyperlipidemia, and obesity;
d
adjusted for age, gender, hypertension, diabetes, hyperlipidemia, and obesity;
e
adjusted for age and gender;
f
adjusted for age, gender, hyperlipidemia, and obesity